Skip to main content
. 2023 May 2;9(5):e15847. doi: 10.1016/j.heliyon.2023.e15847

Table 3.

DSM-5 criteria for substance use disorders.

Options Frequency (%)
Substance Amount I sometimes take the substance in larger amounts or over longer periods than I initially intended to 36 (28.8%)
Tolerance I have felt a need to increase the amount of the medication I use to get the same effect, or I feel that the same amount of medication I always take is not producing the same effect anymore. 23 (18.4%)
Withdrawal I feel depressed, irritable, tired, or shaky whenever I'm not using this medication, or I feel better once I retake the medication. 46 (36.8%)
Craving and difficulty in stopping drug I constantly desire/crave the medication or have tried unsuccessfully to cut down or control my use of these medications 25 (20.0%)
Time spent to obtain and recover from the drug I spend a lot of time and make a lot of effort to acquire this medication, use it or recover from its effect 20 (16.0%)
Effect on major role obligations and social life I have had to reduce some of my social or occupational activities because of the effects of this medication. 8 (6.4%)
Physical and psychological effects I have continued using this medication despite having a physical or psychological problem which is likely due to using it. 10 (8.0%)
Neglected major roles to use; hazardous; social/interpersonal problems related to use I neglected major roles; had social and interpersonal problems with its use, and continued using despite risky/hazardous situations 0 (0%)
Deanxit Use Disorders <2 80 (64.0%)
≥2 45 (36.0%)
Deanxit Use Disorder severity Mild (2–3) 29 (64.4%)
Moderate (4–5) 12 (26.6%)
Severe (≥6) 4 (8.8%)

Data are presented as numbers with percentages.